Infection Surveillance Systems Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Infection Surveillance Systems Market
1.1. Definition and Scope
1.1.1. Definition of Infection Surveillance Systems
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Infection Surveillance Systems Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Infection Surveillance Systems Market By Type
1.2.3. Infection Surveillance Systems Market By End-User
1.2.4. Infection Surveillance Systems Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Infection Surveillance Systems Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Infection Surveillance Systems Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Infection Surveillance Systems Market By Nature
5.1. Introduction
5.2. Infection Surveillance Systems Revenue By Nature
5.2.1. Infection Surveillance Systems Revenue (USD Million) and Forecast, By Nature, 2020-2032
5.2.2. Software
5.2.2.1. Software Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.2. On-Premise
5.2.2.2.1. On-Premise Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.3. Cloud
5.2.2.3.1. Cloud Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Services
5.2.3.1. Services Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.2. Maintenance and Support
5.2.3.2.1. Maintenance and Support Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.3. Consultation and Training
5.2.3.3.1. Consultation and Training Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.4. Implementation Service
5.2.3.4.1. Implementation Service Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Infection Surveillance Systems Market By End-User
6.1. Introduction
6.2. Infection Surveillance Systems Revenue By End-User
6.2.1. Infection Surveillance Systems Revenue (USD Million) and Forecast, By End-User, 2020-2032
6.2.2. Hospitals
6.2.2.1. Hospitals Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Long-Term Care Facilities
6.2.3.1. Long-Term Care Facilities Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.4. Clinics and Ambulatory Surgical Centers
6.2.4.1. Clinics and Ambulatory Surgical Centers Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.5. Other Healthcare Facilities
6.2.5.1. Other Healthcare Facilities Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. North America Infection Surveillance Systems Market By Country
7.1. North America Infection Surveillance Systems Market Overview
7.2. U.S.
7.2.1. U.S. Infection Surveillance Systems Revenue (USD Million) and Forecast By Type, 2020-2032
7.2.2. U.S. Infection Surveillance Systems Revenue (USD Million) and Forecast By End-User, 2020-2032
7.3. Canada
7.3.1. Canada Infection Surveillance Systems Revenue (USD Million) and Forecast By Type, 2020-2032
7.3.2. Canada Infection Surveillance Systems Revenue (USD Million) and Forecast By End-User, 2020-2032
7.4. North America PEST Analysis
CHAPTER 8. Europe Infection Surveillance Systems Market By Country
8.1. Europe Infection Surveillance Systems Market Overview
8.2. U.K.
8.2.1. U.K. Infection Surveillance Systems Revenue (USD Million) and Forecast By Type, 2020-2032
8.2.2. U.K. Infection Surveillance Systems Revenue (USD Million) and Forecast By End-User, 2020-2032
8.3. Germany
8.3.1. Germany Infection Surveillance Systems Revenue (USD Million) and Forecast By Type, 2020-2032
8.3.2. Germany Infection Surveillance Systems Revenue (USD Million) and Forecast By End-User, 2020-2032
8.4. France
8.4.1. France Infection Surveillance Systems Revenue (USD Million) and Forecast By Type, 2020-2032
8.4.2. France Infection Surveillance Systems Revenue (USD Million) and Forecast By End-User, 2020-2032
8.5. Spain
8.5.1. Spain Infection Surveillance Systems Revenue (USD Million) and Forecast By Type, 2020-2032
8.5.2. Spain Infection Surveillance Systems Revenue (USD Million) and Forecast By End-User, 2020-2032
8.6. Rest of Europe
8.6.1. Rest of Europe Infection Surveillance Systems Revenue (USD Million) and Forecast By Type, 2020-2032
8.6.2. Rest of Europe Infection Surveillance Systems Revenue (USD Million) and Forecast By End-User, 2020-2032
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Infection Surveillance Systems Market By Country
9.1. Asia Pacific Infection Surveillance Systems Market Overview
9.2. China
9.2.1. China Infection Surveillance Systems Revenue (USD Million) and Forecast By Type, 2020-2032
9.2.2. China Infection Surveillance Systems Revenue (USD Million) and Forecast By End-User, 2020-2032
9.3. Japan
9.3.1. Japan Infection Surveillance Systems Revenue (USD Million) and Forecast By Type, 2020-2032
9.3.2. Japan Infection Surveillance Systems Revenue (USD Million) and Forecast By End-User, 2020-2032
9.4. India
9.4.1. India Infection Surveillance Systems Revenue (USD Million) and Forecast By Type, 2020-2032
9.4.2. India Infection Surveillance Systems Revenue (USD Million) and Forecast By End-User, 2020-2032
9.5. Australia
9.5.1. Australia Infection Surveillance Systems Revenue (USD Million) and Forecast By Type, 2020-2032
9.5.2. Australia Infection Surveillance Systems Revenue (USD Million) and Forecast By End-User, 2020-2032
9.6. South Korea
9.6.1. South Korea Infection Surveillance Systems Revenue (USD Million) and Forecast By Type, 2020-2032
9.6.2. South Korea Infection Surveillance Systems Revenue (USD Million) and Forecast By End-User, 2020-2032
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Infection Surveillance Systems Revenue (USD Million) and Forecast By Type, 2020-2032
9.7.2. Rest of Asia-Pacific Infection Surveillance Systems Revenue (USD Million) and Forecast By End-User, 2020-2032
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Infection Surveillance Systems Market By Country
10.1. Latin America Infection Surveillance Systems Market Overview
10.2. Brazil
10.2.1. Brazil Infection Surveillance Systems Revenue (USD Million) and Forecast By Type, 2020-2032
10.2.2. Brazil Infection Surveillance Systems Revenue (USD Million) and Forecast By End-User, 2020-2032
10.3. Mexico
10.3.1. Mexico Infection Surveillance Systems Revenue (USD Million) and Forecast By Type, 2020-2032
10.3.2. Mexico Infection Surveillance Systems Revenue (USD Million) and Forecast By End-User, 2020-2032
10.4. Rest of Latin America
10.4.1. Rest of Latin America Infection Surveillance Systems Revenue (USD Million) and Forecast By Type, 2020-2032
10.4.2. Rest of Latin America Infection Surveillance Systems Revenue (USD Million) and Forecast By End-User, 2020-2032
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Infection Surveillance Systems Market By Country
11.1. Middle East & Africa Infection Surveillance Systems Market Overview
11.2. GCC
11.2.1. GCC Infection Surveillance Systems Revenue (USD Million) and Forecast By Type, 2020-2032
11.2.2. GCC Infection Surveillance Systems Revenue (USD Million) and Forecast By End-User, 2020-2032
11.3. South Africa
11.3.1. South Africa Infection Surveillance Systems Revenue (USD Million) and Forecast By Type, 2020-2032
11.3.2. South Africa Infection Surveillance Systems Revenue (USD Million) and Forecast By End-User, 2020-2032
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Infection Surveillance Systems Revenue (USD Million) and Forecast By Type, 2020-2032
11.4.2. Rest of Middle East & Africa Infection Surveillance Systems Revenue (USD Million) and Forecast By End-User, 2020-2032
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Infection Surveillance Systems Market
12.1. Infection Surveillance Systems Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Infection Surveillance Systems Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Becton Dickson & Company
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Million), 2022
13.1.3.2. Becton Dickson & Company 2022 Infection Surveillance Systems Business Regional Distribution
13.1.4. Product /Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. Baxter International
13.3. Premier, Inc.
13.4. Truven Health Analytics Inc. (IBM Watson)
13.5. Gojo Industries, Inc.
13.6. RL Solutions
13.7. Wolters Kluwer N.V.
13.8. VigiLanz Corporation
13.9. Atlas Medical (Roper Technologies)
13.10. Quantros, Inc.
13.11. BD Diagnostics
13.12. ICNet Systems, Inc. (Baxter International)
13.13. Vecna Technologies, Inc.
13.14. bioMerieux, Inc.
13.15. Hygreen Inc.
13.16. Emerald Health Information Systems Ltd.
13.17. DEB Group Ltd.
13.18. Iatric Systems, Inc.
13.19. PeraHealth Inc.
13.20. Cerner Corporation
Frequently Asked Questions
What was the market size of the global infection surveillance systems in 2022?
The market size of infection surveillance systems was USD 540 million in 2022.
What is the CAGR of the global infection surveillance systems market from 2023 to 2032?
The CAGR of infection surveillance systems is 14.7% during the analysis period of 2023 to 2032.
Which are the key players in the infection surveillance systems market?
The key players operating in the global infection surveillance systems market is includes Becton Dickson & Company, Baxter International, Premier, Inc., Truven Health Analytics Inc. (IBM Watson), Gojo Industries, Inc., RL Solutions, Wolters Kluwer N.V., VigiLanz Corporation, Atlas Medical (Roper Technologies), Quantros, Inc., BD Diagnostics, ICNet Systems, Inc. (Baxter International), Vecna Technologies, Inc., bioMerieux, Inc., Hygreen Inc., Emerald Health Information Systems Ltd., DEB Group Ltd., Iatric Systems, Inc., PeraHealth Inc., and Cerner Corporation.
Which region dominated the global infection surveillance systems market share?
North America held the dominating position in infection surveillance systems industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of infection surveillance systems during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global infection surveillance systems industry?
The current trends and dynamics in the infection surveillance systems industry include growing demand for cloud-based infection surveillance systems, increasing adoption of artificial intelligence and machine learning in infection surveillance systems, and expansion of healthcare infrastructure in developing regions and increasing healthcare expenditure.
Which type held the maximum share in 2022?
The software type held the maximum share of the infection surveillance systems industry.?
Select Licence Type
Connect with our sales team
Why Acumen Research and Consulting
100%
Customer Satisfaction
24x7+
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
